Furthermore, an analysis of patients with synovial sarcoma treated in our institute revealed a significant correlation between high TFRC mRNA expression and poor OS for both the full cohort (n = 39, p < 0.005) and the cohort of patients with advanced-stage disease (n = 13, p < 0.05) (Figure S5A,B). This evidence concerns the gene TFRC and synovial sarcoma.